DIABETIC RETINOPATHY DURING CHEMOTHERAPY IN CANCER PATIENTS

Diabetic retinopathy is one of the most common complications of diabetes mellitus worldwide. According to the researchers, from 18 to 50% of cases of diabetes are accompanied by this pathology. In addition to the fact that during the development of diabetic retinopathy, the patient's vision significantly decreases (up to complete blindness), problems with vitreal vessels can cause other complex hemorrhagic lesions. Often, the treatment of diabetic retinopathy is complicated by the presence of a history of other diseases and a side effect of taking drugs that the patient needs for vital signs. In this regard, the clinical case of treating a patient from diabetic retinopathy during chemotherapy will allow to study this problem to a greater extent and make it possible to develop more optimal treatment algorithms in the future.